Tetrasubstituted pyridazine hedgehog pathway antagonists

Details for Australian Patent Application No. 2009314349 (hide)

Owner Eli Lilly and Company

Inventors Bastian, Jolie Anne; Clay, Julia Marie; Cohen, Jeffrey Daniel; Hipskind, Philip Arthur; Lobb, Karen Lynn; Sall, Daniel Jon; Wilson (Nee Takakuwa), Takako; Thompson, Michelle Lee

Agent Spruson & Ferguson

Pub. Number AU-A-2009314349

PCT Pub. Number WO2010/056588

Priority 61/115,332 17.11.08 US

Filing date 5 November 2009

Wipo publication date 20 May 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056588 Priority application(s): WO2010/056588

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314358-Diacylglycerol aclytransferase inhibitors

2009314345-Method of producing serum-free insulinfree Factor VII